← All organizations
Highest phase reached
Phase 4
First clinical trial
Sep 30, 2007Last known activity
Dec 1, 2025
Timeline
No events for the selected filters.
Drugs by trial phase (16 distinct, 15 trials)
Phase 4 (1 own, 0 via acquisition)
Phase 3 (3 own, 0 via acquisition)
Phase 2 (8 own, 0 via acquisition)
Phase 1 (3 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Indications
Studied for
Recent trials (23)
- NCT07201714Lead sponsorEarly Phase 1Dec 1, 2025
- NCT07201714Sponsor investigatorEarly Phase 1Dec 1, 2025
- NCT07177157Lead sponsorPhase 1Oct 31, 2025
- NCT07188246Lead sponsorPhase 2Oct 31, 2025
- NCT07188246Sponsor investigatorPhase 2Oct 31, 2025
- NCT07177157Sponsor investigatorPhase 1Oct 31, 2025
- NCT07076914Lead sponsorPhase 2Oct 2, 2025
- NCT07076914Sponsor investigatorPhase 2Oct 2, 2025
- NCT07073729Lead sponsorN/AAug 1, 2025
- NCT07033767CollaboratorPhase 1/Phase 2Aug 1, 2025
- NCT06820645Lead sponsorPhase 2/Phase 3May 1, 2025
- NCT06396416CollaboratorPhase 4Sep 26, 2024
- NCT05986318Lead sponsorPhase 2Dec 1, 2023
- NCT05986318Sponsor investigatorPhase 2Dec 1, 2023
- NCT06037811Sponsor investigatorPhase 2Nov 30, 2023
Details
- Last known activity
- Dec 1, 2025